Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

Karsten Munk Knudsen

9 posts
NNovo Nordisk
Weight-loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult
Read More

Weight-loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult

  • 2026-08-10
In 2023, Danish drugmaker Novo Nordisk briefly surpassed the luxury conglomerate LVMH to become Europe’s most valuable company…
NNovo Nordisk
Novo Nordisk CFO Knudsen: Oral Wegovy Drives Market Expansion With 80% of Patients New to Obesity Drugs — BigGo Finance
Read More

Novo Nordisk CFO Knudsen: Oral Wegovy Drives Market Expansion With 80% of Patients New to Obesity Drugs — BigGo Finance

  • 2026-08-07
Novo Nordisk delivered what CFO Karsten Munk Knudsen called “one of the bigger guidance hikes we’ve had as…
NNovo Nordisk
[NVO Q2 2026 Earnings Call] Novo Nordisk Raises 2026 Guidance as Wegovy Pill Boom Offsets Pricing Headwinds; 7% Sales Growth, UK Explodes with 300k Patients
Read More

[NVO Q2 2026 Earnings Call] Novo Nordisk Raises 2026 Guidance as Wegovy Pill Boom Offsets Pricing Headwinds; 7% Sales Growth, UK Explodes with 300k Patients

  • 2026-08-05
Novo Nordisk Raises 2026 Guidance as Wegovy Pill Boom Offsets Pricing Headwinds; 7% Sales Growth, UK Explodes with…
NNovo Nordisk
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Read More

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

  • 2026-06-08
Novo Nordisk A/S Bagsværd, Denmark, 12 May 2026 — This company announcement discloses the data of the transaction(s)…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Trading in Novo Nordisk shares by board members, executives and associated persons

  • 2026-05-15
Novo Nordisk A/S Bagsværd, Denmark, 12 May 2026 — This company announcement discloses the data of the transaction(s)…
NNovo Nordisk
Novo Nordisk A/S - share repurchase programme
Read More

Trading in Novo Nordisk shares by board members, executives and associated persons

  • 2026-05-12
Novo Nordisk A/S Bagsværd, Denmark, 12 May 2026 — This company announcement discloses the data of the transaction(s)…
NNovo Nordisk
How Novo Nordisk’s CFO Is Rebuilding Growth
Read More

How Novo Nordisk’s CFO Is Rebuilding Growth

  • 2026-05-12
In 2024, Novo Nordisk was Europe’s most valuable company. Its blockbuster drugs used for weight loss, Ozempic and…
NNovo Nordisk
Novo Shares Tumble on Forecast for Steep Drop in Sales
Read More

Novo Shares Tumble on Forecast for Steep Drop in Sales

  • 2026-02-21
(Bloomberg) — Novo Nordisk A/S shares plunged after the company shocked investors by forecasting a steep decline in…
NNovo Nordisk
Novo Nordisk A/S Q4 Earnings Call Highlights
Read More

Novo Nordisk A/S Q4 Earnings Call Highlights

  • 2026-02-07
Novo Nordisk A/S logo Novo expects a top-line decline of 5%–13% for 2026, attributing the outlook to “extraordinary…
Denmark
www.europesays.com